Author:
Habib Saman,Haq Aqsa Ikram ul,Bashir Shama,Sadiq Nadia,Majeed Noreen,Waheed Nabeela
Abstract
Objective: To determine the frequency of PIH amongst elevated beta-hCG levels and non-elevated beta-hCG in the mid-trimester of pregnancy.
Materials and Methods: It was Descriptive case series conducted for six months (02-12-2019 to 02-06-2020) in OPD of Gynae Unit-II, Holy Family Hospital, Rawalpindi. A total of one hundred and twenty-two (n=122) normotensive pregnant females at 13-20 weeks gestational age and 18-35 years of maternal age were selected in this study after informed consent from every patient. The frequency of PIH in patients with elevated serum beta-hCG was measured. Data were analyzed using SPSS version 20. Effect modifiers were controlled by stratification. A p-value of ≤ 0.05 was considered significant.
Results: Mean beta-hCG levels in the total study population were found to be 7305.09±3900.64 IU/mL. Median b-hCG levels in our study population were noted as 6936.15 IU/mL. Pregnancy-induced hypertension was found positive in 16 (13.1%) patients. Raised beta-hCG levels were present in 10 (8.2%) patients. The frequency of PIH in raised beta-HCG levels was found in 7/10 (70%) of patients. We found a statistically significant (p-value ≤ 0.05) difference in the frequency of PIH among patients with elevated and not-elevated beta-hCG levels.
Conclusion: It is evident from my study that patients with raised levels of serum β-hCG during mid-trimester pregnancy are at increased risk to develop hypertensive disorders of pregnancy. We further elaborated that there is a statistically significant difference in various effect modifiers such as maternal age, gestational age, residential status, and BMI for developing PIH among patients with elevated and non-elevated beta-hCG levels.
Publisher
Rawalpindi Medical University
Subject
Applied Mathematics,General Mathematics
Reference25 articles.
1. Upadya M, Rao ST. Hypertensive disorders in pregnancy. Indian J Anaesth. 2018;62:675–81.
2. Mehta B, Kumar V, Chawla S, Sachdeva S, Mohapatra D. Hypertension in Pregnancy: A Community-Based Study. Indian J Community Med. 2015;40:273–8.
3. Aronow WS. Hypertensive disorders in pregnancy. Ann Transl Med. 2017;5:266-7.
4. Sajith M, Nimbargi V, Modi A, Sumariya R, Pawar A. Incidence of pregnancy-induced hypertension and prescription pattern of antihypertensive drugs in pregnancy. Int J Pharm Sci Res. 2014;5:163-70.
5. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16:e1002783.